Option Care Health (NASDAQ:OPCH) Price Target Cut to $32.00 by Analysts at Barrington Research

Option Care Health (NASDAQ:OPCH) had its target price decreased by equities researchers at Barrington Research from $40.00 to $32.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s price target would suggest a potential upside of 39.62% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $43.00 to $29.00 in a research note on Wednesday. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a research report on Thursday.

Option Care Health Stock Performance

Shares of OPCH opened at $22.92 on Thursday. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The stock has a market cap of $3.92 billion, a P/E ratio of 19.75, a P/E/G ratio of 2.31 and a beta of 1.29. The business’s 50 day moving average price is $30.81 and its 200-day moving average price is $30.02. Option Care Health has a 52 week low of $22.91 and a 52 week high of $34.63.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Equities research analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Transactions at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently made changes to their positions in OPCH. Massachusetts Financial Services Co. MA bought a new position in Option Care Health in the second quarter worth approximately $68,003,000. Magnetar Financial LLC raised its stake in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after buying an additional 1,377,929 shares during the period. Duquesne Family Office LLC raised its stake in shares of Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after buying an additional 1,185,613 shares during the period. Hood River Capital Management LLC lifted its position in shares of Option Care Health by 77.2% during the 2nd quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock valued at $47,894,000 after buying an additional 753,208 shares in the last quarter. Finally, Westfield Capital Management Co. LP grew its stake in shares of Option Care Health by 15.4% during the 1st quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after acquiring an additional 688,653 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.